Boehringer Ingelheim signs option to acquire Trutino Biosciences

Image: Boehringer Ingelheim has a two-pronged research strategy to fight cancers: through cancer cell-directed and immune cell-targeting compounds. Credit: Gerd Altmann from Pixabay.